Dr. Joseph M Schultz , MD
Specialist • Mobile, AL
100 Memorial Hospital Dr Ste 2a
Mobile, AL 366081199
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on December 13, 2005; this date does not establish years in practice.
-
Published CMS data list 3,893 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99215 — Established patient outpatient office visit: 729 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 655 service units.
- 81003 — Automated urinalysis test: 434 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 31 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,951 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 797 prescription fills, including refills.
- Finasteride — 716 prescription fills, including refills.
- Orgovyx (Relugolix) — 208 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Specialist in Mobile, AL (2024, 15 clinicians with data). Median for this group: 1,303. Middle half: 285 to 2,660.
More Medicare Part B services than 80% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: 1,073. Middle half: 294 to 2,658.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,495 in 2020 to 3,893 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
100 Memorial Hospital Dr Ste 2a
Mobile, AL 366081199
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Urology Associates Of Mobile, P.A.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Arkansas College Of Medicine
1994
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
544 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $275,411 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $208,212 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
5,580 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$4,244,057 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $937.83 across 45 records.
By nature of payment
- Food and Beverage: $937.83 across 45 records.
Reporting-company totals (3 largest of 16)
- Janssen Pharmaceuticals, Inc: $134.69 across 6 records.
- UROGEN PHARMA, INC.: $130.24 across 6 records.
- Endo USA, Inc.: $105.78 across 4 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
32 years (graduated 1994)
CMS Doctors and Clinicians data list 1994 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Schultz has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Schultz as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Mobile and Alabama
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Specialist in Mobile, AL (2024, 15 clinicians with data). Median for this group: 1,303. Middle half: 285 to 2,660.
More Medicare Part B services than 80% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: 1,073. Middle half: 294 to 2,658.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Specialist in Mobile, AL (2024, 15 clinicians with data). Median for this group: $67,725. Middle half: $26,614 to $122,105.
A higher Medicare-allowed amount than 85% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: $60,469. Middle half: $20,778 to $147,408.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Specialist in Mobile, AL (2024, 15 clinicians with data). Median for this group: $51,910. Middle half: $18,484 to $90,686.
A higher Medicare payment amount than 85% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: $45,265. Middle half: $15,498 to $105,953.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Specialist in Mobile, AL (2024, 13 clinicians with data). Median for this group: 379. Middle half: 109 to 2,872.
More Part D prescriptions than 80% of clinicians listed under Specialist in Alabama (2024, 145 clinicians with data). Median for this group: 762. Middle half: 186 to 2,437.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Specialist in Mobile, AL (2024, 13 clinicians with data). Median for this group: $9,618. Middle half: $1,918 to $290,757.
A higher Part D drug cost than 95% of clinicians listed under Specialist in Alabama (2024, 145 clinicians with data). Median for this group: $41,558. Middle half: $3,769 to $290,757.
50 active clinicians are listed under Specialist with a practice address in Mobile, AL (545 in Alabama).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Mobile
0% of these 50 clinicians have the CMS telehealth indicator.
26% of these 50 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 56% from 2,495 in 2020 to 3,893 in 2024.
- 2020: 2,495
- 2021: 20,838
- 2022: 2,452
- 2023: 2,714
- 2024: 3,893
-
Medicare-allowed amount
Medicare-allowed amount increased 53% from $179,800 in 2020 to $275,411 in 2024.
- 2020: $179,800
- 2021: $185,409
- 2022: $183,880
- 2023: $215,178
- 2024: $275,411
-
Paid by Medicare
Paid by Medicare increased 56% from $133,413 in 2020 to $208,212 in 2024.
- 2020: $133,413
- 2021: $140,810
- 2022: $137,404
- 2023: $166,263
- 2024: $208,212
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 33% from 2,218 in 2020 to 2,951 in 2024.
- 2020: 2,218
- 2021: 2,128
- 2022: 2,119
- 2023: 2,282
- 2024: 2,951
-
30-day fills
30-day fills increased 19% from 4,672 in 2020 to 5,580 in 2024.
- 2020: 4,672
- 2021: 4,286
- 2022: 4,457
- 2023: 4,722
- 2024: 5,580
-
Part D drug cost
Part D drug cost increased 262% from $1,172,315 in 2020 to $4,244,057 in 2024.
- 2020: $1,172,315
- 2021: $1,768,269
- 2022: $2,341,508
- 2023: $2,378,530
- 2024: $4,244,057
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $811.52 in 2021 to $7,937.83 in 2025.
- 2021: $811.52
- 2022: $864.29
- 2023: $777.12
- 2024: $1,326.33
- 2025: $7,937.83
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 46 records totaling $7,937.83.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Cornerstone Urology Network, LLC |
Common Stock
|
— | Ownership | $7,000.00 |
| Olympus America Inc. |
Food and Beverage
In-kind items and services
|
iTIND System | General | $34.87 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $34.68 |
| C. R. Bard, Inc. & Subsidiaries |
Food and Beverage
In-kind items and services
|
Magic3 Go Intermittent Urinary Catheter | General | $29.87 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $29.81 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $29.29 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $28.83 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $27.29 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
— | General | $25.83 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $25.27 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $25.19 |
| IMMUNITYBIO, INC. |
Food and Beverage
In-kind items and services
|
ANKTIVA | General | $24.92 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
— | General | $24.33 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $23.49 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $22.97 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
— | General | $22.96 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
— | General | $22.76 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $21.32 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
— | General | $20.59 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $20.14 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $20.01 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $19.99 |
| Myriad Genetic Laboratories, Inc. |
Food and Beverage
In-kind items and services
|
PROLARIS | General | $19.72 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $19.63 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $19.42 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
729 | 396 | $206.78 | $161.94 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
655 | 405 | $24.00 | $15.29 |
|
81003
Automated urinalysis test
|
434 | 292 | $8.30 | $2.15 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
320 | 57 | $100.38 | $57.06 |
|
36415
Insertion of needle into vein for collection of blood sample
|
319 | 233 | $17.26 | $8.65 |
|
84153
Psa (prostate specific antigen) measurement, total
|
310 | 232 | $38.81 | $17.84 |
|
99487
Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month
|
157 | 27 | $149.08 | $122.09 |
|
99459
Pelvic exam
|
153 | 141 | $48.00 | $19.12 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
113 | 94 | $152.71 | $117.48 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
105 | 12 | $488.00 | $178.54 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
66 | 66 | $293.39 | $198.62 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
55 | 47 | $430.00 | $202.95 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
52 | 23 | $5.00 | $0.44 |
|
84403
Testosterone (hormone) level, total
|
42 | 28 | $43.00 | $24.32 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
41 | 23 | $151.68 | $106.62 |
|
81002
Urinalysis, manual test
|
36 | 35 | $11.83 | $3.32 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
33 | 31 | $43.00 | $9.06 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
32 | 31 | $292.00 | $159.85 |
|
76872
Ultrasound scan of pelvic region through rectum
|
26 | 23 | $288.00 | $121.65 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
23 | 13 | $55.00 | $30.92 |
|
51784
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
|
22 | 22 | $440.00 | $26.65 |
|
51797
Insertion of device into abdomen with pressure and urine flow rate study
|
22 | 22 | $310.00 | $150.09 |
|
55700
Biopsy of prostate gland
|
21 | 20 | $348.00 | $214.39 |
|
51728
Complex measurement of pressure of urine flow in bladder with voiding pressure studies
|
20 | 20 | $580.00 | $308.33 |
|
72196
Mri scan of pelvis with contrast
|
19 | 19 | $420.00 | $72.13 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 797 | 57,136 | $11,013.65 | 268 |
| Finasteride | Finasteride | 716 | 57,230 | $8,733.57 | 234 |
| Orgovyx | Relugolix | 208 | 6,348 | $551,916.82 | 38 |
| Erleada | Apalutamide | 159 | 4,860 | $2,250,558.08 | 21 |
| Cefdinir | Cefdinir | 118 | 523 | $1,064.55 | 99 |
| Myrbetriq | Mirabegron | 108 | 3,932 | $59,408.79 | 32 |
| Gemtesa | Vibegron | 96 | 3,746 | $58,998.03 | 25 |
| Xtandi | Enzalutamide | 79 | 2,370 | $1,106,737.40 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 76 | 384 | $640.19 | 68 |
| Prednisone | Prednisone | 73 | 2,142 | $384.40 | 20 |
| Abiraterone Acetate | Abiraterone Acetate | 70 | 2,220 | $175,933.87 | 16 |
| Testosterone Cypionate | Testosterone Cypionate | 55 | 1,711 | $1,837.14 | 12 |
| Potassium Citrate Er | Potassium Citrate | 50 | 1,860 | $4,670.38 | — |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 48 | 4,130 | $1,270.73 | 14 |
| Methenamine Hippurate | Methenamine Hippurate | 47 | 1,845 | $3,683.15 | 12 |
| Solifenacin Succinate | Solifenacin Succinate | 38 | 2,010 | $1,436.94 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 377 | $152.11 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 27 | 107 | $147.30 | 25 |
| Bethanechol Chloride | Bethanechol Chloride | 26 | 1,364 | $1,136.52 | 12 |
| Sildenafil Citrate | Sildenafil Citrate | 21 | 606 | $124.21 | — |
| Levofloxacin | Levofloxacin | 18 | 108 | $44.42 | 14 |
| Allopurinol | Allopurinol | 17 | 1,446 | $222.21 | — |
| Trospium Chloride Er | Trospium Chloride | 14 | 455 | $1,226.49 | — |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | 1,125 | $315.73 | — |
| Trospium Chloride | Trospium Chloride | 12 | 600 | $1,378.17 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-03-25NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20090706000143
AL
9739075664
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Urology Associates Of Mobile, P.a.
168 Mobile Infirmary Blvd, Mobile, AL 366073510
Phone: 2514331895
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Specialist
Doctor of Medicine (M.D.)
Nurse Practitioner - Acute Care
Certified Registered Nurse Practitioner
Physician Assistant
Physician Assistant
Specialist
Doctor of Medicine (M.D.)
Nurse Practitioner - Acute Care
Certified Registered Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 100 MEMORIAL HOSPITAL DR STE 2A, MOBILE, AL 366081199 (Tel: 2513439090)
NPI status registered as active in NPPES database
Registered at 101 MEMORIAL HOSPITAL DR, SUITE 100, MOBILE, AL 366081786 (Tel: 2513439090)
Registered at 3719 DAUPHIN ST, SUITE 100, MOBILE, AL 366081753 (Tel: 2513439090)
Recorded as JOSEPH SCHULTZ, M.D.
Specialist (license number reported to NPPES: AL 22500)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Specialists in Mobile
- Dr. Robert Fleming, DPT
- Phillip Bradley, OT
- Dr. Roger Tart, MD
- Terry Breitung, OT
- Dr. James Perrien, MD
- Dr. Jonathan Siegel, MD
Mailing Address
3719 Dauphin St, Suite 100
Mobile, AL 366081753
Phone: 2513439090